Antibody-drug conjugates (ADCs) were associated with a higher risk for all-grade adverse events (AEs) in metastatic breast cancer than standard therapy, according to a meta-analysis. However, these ...

One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma. Bispecific antibodies offer a “targeted and effective alternative” for the ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid plaques and delays cognitive decline. Researchers from VIB and KU Leuven have ...

A new study shows how the single-molecule organization of receptors in a cellular context determines the function of antibodies, opening up new pathways for the development of cancer immunotherapies.

Please provide your email address to receive an email when new articles are posted on . Both vaccinated and post-infection patients with psoriasis were included in this study. Researchers found that ...

Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells. Dr. Amany Keruakous sat down for an interview with CURE, in ...